VYVGART
NDC 73475-3041, EFGARTIGIMOD ALFA, injection, from argenx US.
- Product NDC
- 73475-3041
- Status
- Listed
- Labeler
- argenx US
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761195
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73475-3041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EFGARTIGIMOD ALFA20 mg/mL
Pharmacologic classes
Neonatal Fc Receptor Blocker [EPC]; Neonatal Fc Receptor Blockers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73475-3041-5 | 73475304105 | 1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3041-5) / 20 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8aefc8e3-26d6-4ff6-aab9-a7542927e084Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=73475-3041
Use it
Look up 73475-3041 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73475-3041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73475-3041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.